NCT00542412View on ClinicalTrials.gov

CARE Canadian ALS Riluzole Evaluation

PHASE4CompletedINTERVENTIONAL

Enrollment

414

Participants

Timeline

Start Date

January 31, 2001

Study Completion Date

December 31, 2004

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG

Riluzole

Trial Locations (1)

Unknown

Sanofi-Aventis, Laval

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY

NCT00542412 - CARE Canadian ALS Riluzole Evaluation | Biotech Hunter | Biotech Hunter